Dr. Redner's research interest has been the molecular biology of leukemic transformation and myeloid differentiation. A major focus of his laboratory has been the mechanism underlying differentiation arrest in myeloid leukemia, investigating acute promyelocytic leukemia (APL) as a model system. His group first cloned the NPM-RAR translocation that characterizes the t(5;17) variant of APL, and we have had an active program studying the mechanism by which NPM-RAR generates the leukemic phenotype
UPMC Mario Lemieux Center for Blood Cancers:
5115 Centre Ave #4, Pittsburgh, PA 15232, USA
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: